Tencan: The application for registration and marketing approval of lidocaine and prilocaine cream has been accepted.

On the evening of April 30th, Taencon announced that its wholly-owned subsidiary, Guangdong Taencon Pharmaceutical Factory Co., Ltd., has recently received the "Acceptance Notice" of the registration and listing application for Lidocaine and Prilocaine Cream, a domestically produced drug, issued by the National Medical Products Administration. According to Article 32 of the Administrative Licensing Law of the People's Republic of China, the National Medical Products Administration has reviewed the application for the registration and listing of the drug and has decided to accept it. Lidocaine and Prilocaine Cream is a topical local anesthetic and analgesic agent, suitable for various types of needle punctures and superficial surgical anesthesia of the skin and mucous membranes.